A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker CodevelopmentSheila E. Taube(University of Central Florida), Steven Gutman(CCS Associates (United States))JNCI Journal of the National Cancer InstituteOctober 23, 200910.1093/jnci/djp334Cited by 127SaveCiteExport RISWatch citationsRelated PapersReporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration|PLoS Medicine|2012|1k